Loading
Jürgen Debus is Head of Radiation Oncology at Heidelberg University Hospital and Director of the HIT Heidelberg Ion-Beam Therapy Center, working within the NCT and DKFZ network. His specialisms are particle therapy, carbon-ion radiotherapy and radiation oncology. He leads Europe's pioneering heavy-ion therapy centre, which delivers proton and carbon-ion treatment and runs the trials evaluating them. His paper in Cancer reported carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base | Cancer | 2004 |
Shares A regulatory pathway for new radiotherapy techniques modelled on drug development, Pooled coverage-with-evidence for proton therapy across all centres, Proton therapy.
Shares A regulatory pathway for new radiotherapy techniques modelled on drug development, Proton therapy.
Shares Carbon-ion therapy, Proton therapy.
Shares A regulatory pathway for new radiotherapy techniques modelled on drug development, Pooled coverage-with-evidence for proton therapy across all centres.
Shares Pooled coverage-with-evidence for proton therapy across all centres, Proton therapy.
Shares Pooled coverage-with-evidence for proton therapy across all centres, Proton therapy.
Shares Pooled coverage-with-evidence for proton therapy across all centres, Carbon-ion therapy, Proton therapy.
Shares Pooled coverage-with-evidence for proton therapy across all centres, Carbon-ion therapy, Proton therapy.